Compositions and methods for amplifying nucleic acid sequences
By using polymerizable reagents to form hydrogels in nucleic acid sequence detection, the problems of low detection sensitivity and diffusion interference are solved, efficient and accurate nucleic acid sequence detection is achieved, and the operation process is simplified, and suitable for low concentration and multi-target sequence detection is performed. .
Patent Information
- Application Number
- CN202280091754.5
- Authority / Receiving Office
- CN · China
- Patent Type
- Applications(China)
- Current Assignee / Owner
- Priority Date
- 2021-12-22
- Filing Date
- 2022-12-13
- Publication Date
- 2024-11-01
AI Technical Summary
The prior art has problems such as low sensitivity, interference in diffusion, uneven distribution of amplification products and complex operation in nucleic acid sequence detection, especially when the detection of low-concentration target sequences and simultaneous detection of multiple target sequences is difficult to achieve accurate results.
Using a composition containing a polymerizable reagent, a local hydrogel is formed by light or thermal stimulation, the target nucleic acid sequence is encapsulated, the diffusion is controlled and the local amplification reaction is realized, the operation process is simplified and the detection accuracy is improved.
Achieve high-sensitivity nucleic acid sequence detection, reduce diffusion interference, ensure the encapsulation and distribution uniformity of amplified products, simplify the operation process, and is suitable for low-concentration and multi-target sequence detection, improving the accuracy and efficiency of detection .
Smart Images

Figure CN118891376A_ABST
Abstract
Description
[0001] The present invention relates to a composition for amplifying a nucleic acid sequence, and a method for amplifying a nucleic acid sequence using the composition. The present invention also relates to a device specially designed for using the composition.
[0002] More generally, the field of the invention is the detection of nucleic acid sequences by amplification reactions such as PCR or any other in vitro amplification method in a controlled scattering medium compatible with these methods.
[0003] In molecular biology, it is often necessary to identify the presence of one or more target nucleic acid sequences (or target nucleic acid sequences) in a sample with high accuracy and confidence. Therefore, the relative or absolute concentration of these target sequences can be measured.
[0004] For example, the target sequence can be composed of a DNA sequence, such as a gene fragment present in a human or animal pathogen genome in a specific manner. Therefore, the target sequence allows identification of the pathogens carrying them, or characterizes their pathogenicity or the ability of them to tolerate one or more antibiotics or one or more antiviral molecules. The target sequence can also be composed of a DNA sequence outside the gene, such as telomere, transposon or retrotransposon. Some target sequences can be distinguished from each other by one or more point mutations, i.e., the change of a base to another base (English "single nucleotide polymorphism"), or the addition or deletion of a base or several bases. The target sequence can also be made of RNA, such as gene transcripts, microRNA, non-translated RNA or viral RNA derived from RNA viruses and retrotransposon transcripts. In some cases, the target sequence is an artificial DNA sequence used as a barcode or "tag". Particularly the sequence covalently bound to the antibody used in the so-called immune PCR method, or the situation of the sequence (English "padlock probes") integrated into the padlock probe.
[0005] The target nucleic acid sequence may be in different states in the sample. Thus, the sequence in the sample may be free, possibly after a processing step of the sample, or included in biological particles such as viruses, prokaryotic or eukaryotic cells, or organelles such as mitochondria. In this case, the nucleic acid sequences are usually selected so that they allow identification of biological particles, or identification of genotypes or specific characteristics therein.
[0006] Independent of the state of the sequences, when they are present in quantities too low to be directly characterized, the methods generally used to detect them consist in carrying out an in vitro amplification of these sequences in order to obtain sufficient quantities to enable their characterization. This amplification is carried out using a mixture of oligonucleotide primers located in the target sequence. The addition of one or more oligonucleotide probes conjugated to a fluorophore generally allows the presence or absence of the target sequence and their quantity to be characterized.
[0007] A well-known amplification method is the polymerase chain reaction PCR (English: "Polymerase Chain Reaction"). PCR is an in vitro exponential amplification process. This is currently the most commonly used amplification process. In addition to PCR, there are other alternative methods, such as the LCR method (English: "Ligation Chain Reaction"), the NASBA method (English: "Nucleic Acid Sequence-Based Amplification"), the TMA method ("Transcription Mediated Amplification"), the LAMP method (English: "Loop-Mediated Isothermal Amplification"), the SDA method (English: "Strand Displacement Amplification") and the so-called RCA rolling circle amplification (English: "Rolling Circle Amplification").
[0008] PCR and other in vitro amplification reactions are usually carried out in a liquid reaction medium containing different reagents. These are usually composed of primers, fluorescent probes specific for the target sequence, enzymes for amplifying nucleic acids, optional additives, and samples to be analyzed (including the target sequence). During the amplification reaction, reagents and the products (so-called amplicons) produced by the reaction are freely diffused into the liquid volume of the reaction medium. This free diffusion in the liquid reaction medium is due to several disadvantages, which are prohibited for certain applications.
[0009] It is considered that in some applications, the target sequence is present in a small amount in the sample (e.g., 1 to 10 molecules). Therefore, a process for ensuring very high sensitivity detection should be provided. In particular, in the case of specific nucleic acid sequences in in vitro diagnostic human blood samples, it can, for example, indicate the presence of genetic diseases in sepsis, tumors, or fetuses (detected in so-called liquid biopsies). Even if the amplification method is theoretically capable of detecting a single molecule of the target sequence, in practice, the diffusion of the amplicon into the reaction mixture has the effect of delaying the time point of the reaction, at which point the intensity of the signal emitted by the amplicon and the intensity of the signal measured by the detector of the device used locally exceed the level of the background noise of the detector. This delay may make it possible that the amplicon is not finally detected during the reaction, resulting in a false negative result.
[0010] In the application of multiple target sequences in the same reaction mixture, free diffusion also brings problems. This is especially true in applications related to the diagnosis of infectious diseases, where it is necessary to identify the pathogens involved at the same time, as well as their genotypes of resistance to antibiotics or antiviral molecules. Although the solution to meet this requirement may be to detect each target sequence in a single type test, it seems that this solution is restrictive, and it is particularly desirable to perform the detection of all target sequences in a single reaction. The reason may be an emergency, a small size of the sample, a low concentration of the target sequence in the sample, or the cost of the test (reagents, consumables, occupancy of automatic devices, etc.). However, the free diffusion of the amplicon derived from the target sequence mainly present in the sample has the effect of interfering with the amplification of other minority target sequences in the sample. This is especially due to the competition for reagents required for the amplification reaction. Therefore, there is a permanent risk that one or more minority target sequences are not detected in the sample.
[0011] In other applications, it is desirable to measure the amount of a target sequence present in a sample. Thus, an accurate quantification or measurement of the distribution is desirable. More particularly, it is sometimes necessary to ensure that a target sequence present in large quantities in a sample does not interfere with the measurement of the concentration of other target sequences present in small quantities (e.g., 10, 100, or 1,000 times less abundant). Such measurements are not possible when the target sequence and its amplicons diffuse freely in the reaction mixture.
[0012] In order to overcome some of the above problems, the prior art proposes different methods.
[0013] In particular, there is a method for in situ PCR amplification. This method is useful when the target sequence is included in the cell. Therefore, in situ PCR includes a step of amplifying DNA or local RNA to improve the sensitivity and specificity of hybridization. In this technology, amplification can be performed in a solution. For this purpose, the cell should be fixed and permeable so that the PCR reagents can enter the cell. Amplification can also be performed on formalin-fixed tissue sections (US5364790, US5538871 and US5804383). The main disadvantage is the permeabilization of the cell so that the reagents can penetrate therein. This permeabilization enables the amplicon to diffuse. This makes the method of characterizing the amplified product in the liquid phase inapplicable. Therefore, in order to perform the step of detecting the amplicon fixed in the cell, it is necessary to manipulate the sample after amplification. This prolongs the duration of the reaction and increases the complexity of the reaction and its analysis. In addition, increasing the risk of cross contamination is an expensive operation. For these reasons, in situ PCR is particularly unable to meet the needs of multi-genotyping (Uhlmann et al., 1998).
[0014] Another method is the so-called digital amplification or digital PCR method. In this method, the reaction mixture is divided into a large number of different small volume compartments (for example, within the range of one microliter). The compartments are selected so that each compartment contains only one molecule of the target sequence at most. This physical compartmentalization can be achieved, for example, by using a microfluidic system to produce an emulsion of reaction medium droplets in an oily liquid. It can also be obtained by filling a microfluidic device composed of a large number of small volume cells. Regardless of the method for obtaining it, this compartmentalization allows a large number of completely different amplification reactions to be performed without passing the reaction mixture from one compartment to another. Detect and count the compartments in which the amplification reaction is obtained. The counting allows the number of molecules of the target sequence present in the sample to be accurately quantified. Therefore, digital PCR allows the presence of a few target sequences to be quantified in a single reaction [Sensors (Basel) 2018, 18 (4), 1271; J. Med. Virol. 2021, 93 (7), 4182-4197]. However, it is necessary to carry out a digital PCR reaction with complex and expensive equipment. In particular, the compartmentalization of the reaction mixture requires complex operations. Furthermore, digital PCR cannot maintain the advantages of so-called real-time PCR (especially the measurement of Ct).
[0015] A promising method is to perform PCR in a gel matrix and measure the PCR products produced in each cycle. PCR can be performed in polyacrylamide gels (PAM) (Anal. Biochem. 2006, 356, 300-302) or PEG derivatives. Therefore, the reaction produces different molecular colonies, which are sometimes referred to as "polymerase colonies (polonies)" (P. Blainey et al. US10487354; Huang et al. US2019 / 0202268; Huang et al. US2019 / 0202268; GM Church et al. US6485944; ABChetverin et al. P1999268; ABChetverin et al. US6001568). The main advantages of these matrices are as follows: i) at a suitable mesh size, they delay the diffusion of linear molecules, so that the target molecule and its amplification product remain in close proximity; ii) the number of polymerase colonies formed is proportional to the number of target molecules initially present in the sample, which facilitates quantification in a manner similar to digital PCR; and iii) at least one primer can be fixed to the gel by covalent bonding. Nevertheless, the main disadvantage of the gels of the prior art is that they are incompatible with applications outside the laboratory. For example, the technology of the prior art is not suitable for rapid diagnostic applications. This is particularly due to the gelation process that cannot be controlled spatially or temporally. In addition, in the case of PAM gels, the target molecules and amplification reagents should be incorporated into the gel formed after rinsing with buffer in order to extract the acrylamide monomers that have not been polymerized due to their high inhibitory effect on the PCR amplification reaction.
[0016] The present invention improves this situation.
[0017] Therefore, the present invention relates to a masterbatch composition for amplifying nucleic acid sequences, which is intended to be mixed with a biological sample containing one or more target nucleic acid sequences and primers specific for the target nucleic acid sequences, as well as fluorescent probes for revealing the amplification of the target nucleic acid sequences, the composition comprising reagents and nucleic acid amplification enzymes, characterized in that the composition also comprises a polymerizable reagent, which polymerizes under the influence of a stimulus selected from thermal stimulation and light stimulation, so as to form a hydrogel that locally encapsulates each target nucleic acid sequence when the composition is exposed to the stimulus.
[0018] Therefore, the present invention allows the amplification reaction of nucleic acid sequences in a culture medium with controlled component diffusion. Therefore, the present invention allows local encapsulation of target nucleic acid sequences. This leads to a large number of advantages, particularly relevant to the local control of nucleic acid detection and / or amplification reactions.
[0019] In one embodiment, the polymerizable agent is a photosensitive agent that polymerizes when exposed to light, preferably ultraviolet light. This allows precise control of the initiation of controlled polymerization of the compositions of the invention.
[0020] The polymerizable agent may also be a thermosensitive agent that will polymerize when exposed to a temperature above a threshold temperature.An advantage of this embodiment is that the temperature domain used in isothermal or non-isothermal nucleic acid amplification methods can be used directly.
[0021] Preferably, the polymerizable reagent comprises already polymerized chains, advantageously only the terminal functions of which are reactive, to more easily control the size of the pores of the gel. These already polymerized chains can be selected from water-soluble polymers (e.g. PEG, PAM, biopolymers, etc.) that do not inhibit or hardly inhibit PCR.
[0022] Typically, the polymerizable agent can be a poly(ethylene glycol) having multiple arms (ie, multiple-arm PEG, or multi-arm PEG).
[0023] Still more generally, the polymerizable agent is advantageously pre-polymerized and / or water soluble and biologically inert (so as not to interfere with the amplification reaction) and / or capable of polymerizing (eg, possessing an activatable functionality or natural free radicals).
[0024] Thus, in a specific embodiment, the polymerizable agent is selected from multi-arm PEG (multi-arm PEG) and its derivatives.
[0025] The polymerizable agent may be selected from four-arm-PEG-SH, four-arm-PEG-norbornene, two-arm-PEG-SH, eight-arm-PEG-norbornene (tripentaerythritol), eight-arm-PEG based on nitrocinnamate, or mixtures thereof. These are photosensitive agents polymerizable by light at a selected wavelength, and thus contribute to the precision of the controlled polymerization of the compositions of the present invention.
[0026] Advantageously, the photopolymerizable agent is a mixture of two-arm-PEG-thiols and eight-arm-PEG-norbornene or a mixture of four-arm-PEG-thiols and four-arm-PEG-norbornene in the presence of lithium phenyl-2,4,6-trimethylbenzoylphosphite (LAP) photoinitiator.
[0027] The polymerizable agent may be a four-arm-PEG-acrylate. This is an agent that polymerizes in the presence of a thermal initiator when the thermal initiator is exposed to a given temperature.
[0028] Advantageously, the thermosensitive polymerizable agent is a mixture of four-arm-PEG-acrylates in the presence of a thermal initiator, 2,2'-azobis[2-(2-imidazolin-2-yl)propane dihydrochloride].
[0029] More generally, the photosensitive polymerizable agent can be chosen from water-soluble polymers with unsaturated functional groups (norbornene, nitrocinnamate, etc.) or without unsaturated functional groups (thiols) or mixtures thereof. These are agents capable of forming reactive intermediate species, preferably free radicals or free radical ions, by applying light of wavelength between 200 and 800 nm, preferably between 300 and 450 nm, in the presence of an activator (polymer itself or photoinitiator).
[0030] Furthermore, the thermosensitive polymerizable reagents may be selected from water-soluble polymers with olefinic (acrylate, acrylamide, etc.) functional groups or mixtures of activated unsaturated functional groups (maleic anhydride, maleimide, etc.) with conjugated 1,3-dienes (furan, thiophene, etc.) These are reagents capable of forming reactive intermediate species, preferably free radicals or free radical ions, or participating in cycloaddition reactions by applying a threshold temperature comprised between 30 and 95°C, preferably between 50 and 80°C.
[0031] In one embodiment, the polymerizable agent is present in an amount of 2 to 25 weight %, preferably 5 to 15 weight % per unit volume (w / V %).
[0032] In one embodiment, the composition further comprises a polymerization initiator. It may consist of a photoinitiator or a thermal initiator. The initiator is present in an amount of 0.02% by weight to about 0.1% by weight per unit volume (w / V). Preferably, the photoinitiator is lithium phenyl-2,4,6-trimethylbenzoylphosphinate (LAP), and the thermal initiator is 2,2'-azobis[2-(2-imidazoline-2-yl)propane dihydrochloride]. This agent allows for the initiation of polymerization to be promoted, and thus contributes to the controlled polymerization of the composition of the present invention.
[0033] In addition, the composition may contain a developer, preferably fluorescent, of the presence of the nucleic acid sequence from the outset. The developer may be a fluorescent intercalator of the nucleic acid or a fluorescent probe specific for the sequence combined with a fluorescent quencher. The developer provides better detection of the amplified nucleic acid during or at the end of the amplification reaction.
[0034] The composition may also contain primers specific to the target nucleic acid sequence from the outset. This particularly allows the preparation of a masterbatch specifically designed to identify known pathogens. In this embodiment, it is also advantageous to directly include a specific probe in the composition to reveal the presence of the amplified target nucleic acid sequence.
[0035] In a preferred embodiment of the present invention, the composition of the present invention remains in a liquid state for a period of several hours to several months, preferably several days to several months, before the application of the stimulus, and the composition forms a hydrogel within a period of shorter than or equal to 10 minutes, preferably shorter than or equal to 1 minute after the application of the stimulus.
[0036] Of course, the composition is stable over a period of time, i.e. during and after the period during which the composition remains liquid (or very slightly viscous), thereby functioning as a composition for amplifying nucleic acid sequences. "Stable" is to be understood in particular as the fact that the reagent does not degrade (or hardly degrades) under normal storage conditions (e.g. in a refrigerator, at room temperature, protected from light, etc.).
[0037] The present invention also relates to a method for amplifying a nucleic acid sequence, which comprises the following steps: (i) providing a composition of the present invention; (ii) mixing the composition with a biological sample to be analyzed; (iii) applying a stimulus selected from thermal stimulation and light stimulation to polymerize the mixture of step (ii) to obtain a hydrogel; and (iv) exposing the hydrogel to an acid sequence amplification reaction.
[0038] Step (ii) may comprise mixing the composition with primers specific for the target nucleic acid sequence and / or specific for the specific probe to reveal the presence of the amplified target nucleic acid sequence.
[0039] In one embodiment, step (i) is maintained for a period of between a few hours (eg 1 to 5 hours) to several months (eg 1 to 18 months), preferably between a few days (1 to 15 days) to several months (2 to 6 months).
[0040] The key point of the method of the present invention is that the polymerization in step (ii) starts only after applying light or heat stimulation. Therefore, the light stimulation can be the application of light with a wavelength between 200nm and 800nm, preferably between 300nm and 450nm; and the heat stimulation can be the application of a threshold temperature comprised between 30°C and 95°C, preferably between 50°C and 80°C for a period of time shorter than 10 minutes.
[0041] Advantageously, the period between providing the composition and applying the stimulus is longer than 1 hour, preferably longer than 1 month, which avoids preparing the composition prior to use.
[0042] In other words, the compositions of the present invention can be stored for periods longer than 1 month, and may last up to 6 months or longer.
[0043] Better yet, each step of the method can be characterized by duration: storage of the composition containing the polymer and amplification reagents (t0), depending on its composition and storage conditions, up to several months; treatment of the same composition once stored and allowed to exist in the target under ambient conditions without gelation (t1), which can last for several hours; and gelation upon application of a stimulus (light or temperature) (t2), which is less than 10 minutes.
[0044] In other words, the composition comprising a polymerizable agent is stable for a very long time of up to several months. This is very advantageous for storage conditions. The composition can then be mixed with the target sequence without the need for a polymerization process to convert the solution directly into a gel. In practice, gelation is very slow and the formation of gel is observed only after a few hours. This creates another great advantage, namely that there is no need to rush in the laboratory. In particular, this allows several samples to be prepared in parallel. Therefore, the polymerization of several samples can be initiated in parallel in the same stimulation operation. The gelation of all samples lasts only a few minutes. The target sequence amplification process can then be started for all parallel samples. Therefore, in a specific embodiment, a hydrogel is obtained within a time period of less than or equal to 10 minutes, preferably less than or equal to 1 minute, after applying the stimulation of the method of the present invention.
[0045] The hydrogel formed by the composition of the present invention encapsulates the amplification reagents and the target nucleic acid sequence. The amplification reaction of the nucleic acid sequence is then carried out locally at different locations of the gel. The amplification product remains encapsulated in the hydrogel. In other words, the diffusion of the composition components and the diffusion of the amplification reaction products are controlled. This leads to a large number of advantages, particularly those related to the analysis and detection of nucleic acids.
[0046] In one embodiment, the amplification reaction is a polymerase chain reaction.
[0047] In one embodiment of the invention, polymerization is initiated by exposing the composition to ultraviolet light (when the polymerizable agent is photosensitive) or a threshold temperature (when the polymerizable agent is thermosensitive). The polymerization may involve a reaction selected from a bioorthogonal thiol-ene reaction and a dimerization reaction.
[0048] Other advantages and features of the present invention will become apparent from a reading of the following detailed description and accompanying drawings, in which:
[0049] [ Figure 1 ] shows a schematic diagram of the present invention;
[0050] [ Figure 2 ] shows a photograph of a hydrogel formed by the composition of the present invention and a photosensitizer having different initial concentrations of target sequences, and a graph corresponding to PCR data of the first embodiment of the present invention;
[0051] [ Figure 3 ] shows two photographs of a hydrogel formed from a composition of the present invention of a first embodiment; and
[0052] [ Figure 4 ] shows the target sequences with the same initial concentration (10 3 Photographs of hydrogels formed from different embodiments of the compositions of the present invention (copies).
[0053] The drawings, tables and descriptions which follow contain elements of a certain nature in essence. The drawings and tables form an integral part of the description and therefore serve not only to provide a better understanding of the invention but also to contribute to its definition, where appropriate.
[0054] Generally, the present invention relates to a composition comprising a polymerizable agent. The composition is biocompatible and has a low viscosity at room temperature. Therefore, the composition of the present invention allows the target molecule or target cell to be mixed with a reagent for amplifying a nucleotide sequence at room temperature. This has the advantage that the operation of the laboratory operator can be carried out in the usual manner. The composition of the present invention has the particularity of being able to quickly form a uniform network hydrogel by a polymerizable agent. When exposed to a triggering factor such as light stimulation or a threshold temperature, the polymerizable agent triggers the polymerization of the composition. The composition of the present invention ensures sufficient sensitivity of PCR, particularly due to the analysis of gel images. When the composition of the present invention is in a gel state, it can carry out a nucleic acid amplification reaction.
[0055] The composition of the present invention in a gel state has a matrix capable of withstanding the rapid temperature changes typically required during an amplification reaction. In addition, the composition in gel form maintains its structural integrity under the influence of different physical and / or chemical constraints applied during nucleic acid amplification.
[0056] The object of the present invention is to prepare a gel matrix with a uniform structure. The gel has an appropriate mesh which greatly restricts, or even prohibits, the diffusion of target molecules and amplification products, while allowing the diffusion of amplification reagents to carry out nucleic acid amplification reactions. This object is achieved by the main claim attached to the description of the present invention.
[0057] Generally, hydrogel is a network of three-dimensional (3D) cross-linked polymers that can absorb and retain a large amount of water. Due to their adjustable properties and their general manufacturing methods, hydrogels are used in a wide range of biomedical applications and technologies. For example, tissue engineering and regenerative medicine or wastewater treatment or robotics can be mentioned. Generally, hydrogels are formed by covalent bonds and / or non-covalent bonds of monomers or chains of prepolymers such as hydrogen bonds, electrostatic interactions, so-called host-guest complexes (English "host (main) -guest (guest)") and combinations thereof (W.Wang, R.Narain, H.Zeng.Polymer Science and Nanotechnology, Fundamentals andApplications (polymer science and nanotechnology, basic principles and applications), 2020, Pages 203-244).
[0058] The prior art describes gel matrices for nucleic acid amplification. These gel matrices are formed in polymerization reactions according to two basic mechanisms: chain polymerization and stepwise polymerization.
[0059] Chain polymerization ("chain growth polymerisation" in English) consists in forming polymers from unsaturated monomer molecules (in particular acrylamide, methacrylamide, acrylic acid, methacrylic acid, bisacrylamide, styrene, etc.). This type of reaction requires an initial activation of the unsaturated bonds. In other words, it is necessary to form reactive species (free radicals, cations) in advance. For example, reactive free radical particles can be formed after activation of specific compounds, so-called initiators. The activation of the initiator can be carried out using photons, heating, oxidation-reduction potential or enzyme activity. Initiators have free radical centers and are therefore able to easily transfer free radicals to reactive molecules. Thus, free radicals are formed in a cascade manner. In summary, once the initiator is added and a stimulus is applied, if appropriate, free radicals begin to be generated and initiate polymerization. During the growth of the polymer, chains comprising monomer units are formed. Monomers are gradually added at the ends of the polymer chains. The polymerization process can be interrupted, especially when high conversions are reached, several different chains suddenly recombine with each other or free radical inhibitor compounds are present in the reaction medium. Oxygen is generally used as free radical inhibitor. Therefore, it is preferred to degas before the polymerization and / or to apply inert conditions during the latter. This requires complex manipulations and involves a lot of laboratory equipment, such as desiccants, inert gas tanks or inert gas lines, pumps, etc. In addition, chain polymerization results in the formation of chains of different lengths, which creates irregularities in the gel matrix. The gel matrix also contains heterogeneous lateral bonds with high molecular weights, which results in a hydrogel composed of meshes of different sizes. Therefore, the structure of the gel is generally incompatible with nucleic acid amplification reactions. On the other hand, free radical polymerization is generally rapid and therefore hardly controllable, or even completely uncontrollable.
[0060] Stepwise polymerization involves different types of reactions of difunctional or multifunctional monomers (prepolymers). In particular, Michael-type conjugation reactions based on thiols involving PEG derivatives are commonly used in this type of polymerization. By definition, the functional groups of monomers or prepolymers are reactive sites and are therefore able to react directly with each other. Unlike chain polymerization, dimers, trimers and tetramers are formed at the beginning of polymerization. These oligomers then bind to each other to form long polymer chains. Typically, the polymers formed by this type of polymerization do not have any heterogeneous lateral bonds [Biomacromolecules (biomacromolecules) 2012, 13 (8), 2410-2417; J.Appl.Polym.Sci.2015, 132, 8]. This ensures a certain uniformity of the mesh. For this purpose, this type of gel matrix is preferably used for PCR applications, such as forming polymerase colonies. However, the structure of the gel is very compact, which is generally incompatible with nucleic acid amplification reactions. In addition, stepwise polymerization can occur quickly after mixing reagents. Therefore, some of these reactions are also barely controllable or even completely uncontrollable.
[0061] In addition to the uncontrollable nature of the polymerization reaction and the inappropriate structure of the gel, there are other disadvantages, some of which are discussed below.
[0062] The reaction time of the known gelation methods such as those described above (acrylamide-bis-acrylamide copolymers and multi-arm PEG-acrylate / PEG-SH copolymers) generally requires between 10 minutes and 30 minutes at room temperature or at a temperature between 20°C and 40°C to form an almost complete polymer structure [P. Blainey et al. (US10487354); Huang et al. (US2019 / 0202268); GM Church et al. (US 6,485,944); ABChetverin et al. (EP1999268); ABChetverin et al. (US6001568)]. This duration reduces the effectiveness of amplification reagents (enzymes, fluorophores, etc.) that are generally sensitive to temperature. In addition, this duration is not suitable for all applications where the rapidity of the test is important, for example, so-called patient bedside applications (English "Point-of-Care Testing"). For such applications, a gelation time period in the range of one minute would be ideal.
[0063] The start of the polymerization reaction is not controllable in the prior art. In fact, in the case of PEG-acrylate-PEG-SH hydrogels with step growth, the reaction starts as soon as the components are mixed, while in the case of acrylamide-bis-acrylamide hydrogels with chain growth, the reaction starts as soon as the components are mixed with a polymerization initiator (e.g. APS-TEMED). This complicates the operation for the user (especially when speed is required) and affects the reproducibility of the protocol due to the high probability of forming defects in the gel matrix during mixing and then injection into the reaction chamber.
[0064] In addition, it is impossible to automate the known polymerization method, because the operation with 100 to 1,000 copies of reaction and more copies requires the preparation of 2 to 5 batches of maximum reactions separately. This also complicates the use of amplification chambers of different shapes (boxes, narrow or elongated reaction chambers, i.e. rod-type or capillary reaction chambers, particularly folded or wound in flat boxes so as to be able to be placed in standard PCR cyclers), which limits their number to the number that can be filled quickly. More specifically, in the known gel amplification method, once polymer is introduced into the mixture, the viscosity of the reaction mixture increases. It can be seen that the reaction mixture is rapidly gelled, and it is necessary to introduce it rapidly into the amplification reaction chamber. If this cannot be done, the gelled mixture will block the entrance of the chamber. Then, the mixture becomes unavailable and amplification fails.
[0065] Chain radical reactions, for example in the case of acrylamide-bis-acrylamide gels, are reactions that are sensitive to the presence of oxygen in the air. Oxygen inhibits polymerization and contributes to the formation of a network containing heterogeneous crosslinks with a high molecular weight. This results in a hydrogel consisting of meshes of different sizes. Therefore, it is preferred to carry out a degassing process before the polymerization reaction and / or to apply inert conditions during the polymerization reaction. This requires complex manipulations and the use of several laboratory equipment, such as desiccators, inert gas tanks or inert gas pipes, pumps, etc.
[0066] In addition, the main disadvantage of these gels is that unreacted acrylate monomers are harmful to the amplification reaction. Attempts have been made to solve this problem by additional washing steps (ABChetverin et al. in EP1999268 and US6001568). However, this increases the complexity of the process by adding long steps that are usually associated with yield loss. In fact, the method for preparing the gel includes: a) treating the glass surface with an adhesive-silane-water-ethanol-acetic acid mixture to fix the gel (about 2 hours); b) degassing the prepolymer solution (at least about 15 minutes); c) incubating at 4°C for 1 hour, then quickly adding the initiator and gelling at room temperature for about 40 minutes; d) washing the gel for about 60 minutes, then drying overnight at room temperature; e) diffusing the amplification reaction mixture into the gel. Therefore, the whole process lasts for about 13 hours or longer. In addition to time constraints, another major disadvantage of this type of method is that it makes it almost impossible to use these gels for target molecules of different sizes (DNA, RNA, bacteria, viruses). This is particularly due to the problem of diffusion within the gel, which leads to uneven distribution of the amplification product.
[0067] In the case of nucleic acid amplification reactions, the preparation of the gel should take into account a large number of factors. In particular, mention may be made of the physical stability of the gel, its inertia, the toxicity of the components, the compatibility of the gel with the reagents of the amplification reaction and the compatibility of the gel with the amplification conditions (i.e. the influence of the components of the gel on the amplification reagents on the one hand and the influence of the amplification reagents on the gelation on the other hand).
[0068] Attempts have been made to prepare PEG-based gels, in particular copolymers of PEG four-arm acrylates and PEG two-arm thiols, and to apply nucleic acid amplification reactions therein (P. Blainey et al. in US10487354 or Huang et al. in US2019 / 0202268). Nevertheless, the difficulty caused by the too fast triggering of polymerization and its uncontrollable nature makes industrialization impossible.
[0069] In practice, the problems encountered in this field are varied and multiple, and in summary, mention may be made of: long preparation methods; too rapid and uncontrollable initial polymerization; too long a time for gel formation; reproducibility problems; formation of non-uniform gels; complex manipulations; degassing or manipulations under an inert atmosphere; protocols in a large number of steps; the need to wash the gel in order to eliminate potential inhibitors of nucleic acid amplification; and the need for several laboratory equipment (dryers, inert gas containers or inert gas lines, pumps, washing baths, etc.).
[0070] All this means that solutions for nucleic acid amplification (particularly PCR) techniques cannot be prepared in a satisfactory manner in gels. Furthermore, to date, there is currently no commercial and / or industrial gel amplification technique.
[0071] Applicants have developed compositions and methods for amplifying hydrogel nucleic acids that solve the problems of the prior art. Thus, the present invention does not require complicated procedures and uses non-toxic reagents that are compatible with nucleic acids and their enzymatic amplification. Polymerization using the compositions of the present invention can be controlled by a polymerizing agent that is sensitive to light and / or temperature. The polymerizing agent of the present invention is photosensitive and / or thermosensitive.
[0072] In particular, the present invention provides (i) operational simplicity, (ii) speed, (iii) controllability, and (iv) significantly increased storage compared to the previous state. In fact, the present invention allows (i.1) to prepare the amplification reaction in a single step, and without complicated operations. In addition, (i.2) no degassing step (usually related to oxygen sensitivity) is required. The preparation of (ii.1) is fast, that is, especially without washing. For example, there is no need to wash the gel to eliminate any amplification enzyme inhibitors. (ii.2) Gelation is very fast and only after applying a stimulus (luminescence or heat). (iii.1) The stimulus is controllable in space and time, and is perfect (iii.2) reproducibility. (iii) The size of the polymerase colony is uniform, which particularly allows further control of the amplification process. The ingredients of the composition of the present invention make it possible to mix (iv.d) before applying the stimulus without any risk of gelation. (iv.2) Long-term storage and the completion of a large number of (iv.3) operations in parallel. It is possible for the present invention.
[0073] In particular, the invention relates to polymerization induced by light or by threshold temperature of one or more monomers or prepolymers, with or without photoinitiators or thermal initiators.The polymerization of the invention combines the advantages of the two polymerization mechanisms (chain and step-growth) described above.
[0074] Photopolymerization and thermal polymerization are part of the chemical process of forming hydrogels. They are carried out by exposing a photosensitive or thermally sensitive system consisting of unsaturated components with / without photoinitiators or thermal initiators (with / without other components with photo / thermosensitive functional groups) to ultraviolet light (~200 to 400nm) or visible light (~400 to 800nm) or at elevated temperatures (above room temperature).
[0075] In this description, and for the definition of the present invention, by "stimulus" or "stimuli" it is to be understood any chemical or physical element or factor which triggers polymerization.
[0076] The main advantage of the polymerization activated by photons (photoactivation) or by heat (thermal activation) is that the hydrogel is formed in situ from an aqueous solution in a minimally invasive manner and with controlled triggering of the gelation process. This is possible due to the use of external stimuli applied to the reagents. The stimulus used in the present invention is respectively a targeted irradiation of the prepolymer with light of a selected wavelength or an exposure of the monomer (also a prepolymer) with a threshold temperature. The possibility of regulating the intensity and duration of the exposure to light or temperature by the PCR device allows additional control over the gelation and thus over the properties of the produced gel (control of the swelling rate, mechanical strength, degradability, etc.).
[0077] About photoactivation: light can be directed to a specific position and to a defined time point. This allows different technical designs to be performed on the amplification chamber. The use of light energy enables polymerization under simple reaction conditions at low doses of initiator free radicals. Typically, photopolymerization is defined by a fast polymerization rate (about a few minutes) and a minimum heat production. This is particularly important for the stability of the amplification system (Biomaterials 2002, 23, 4307-431). These advantages make this method of forming a hydrogel particularly suitable for in vivo applications, encapsulation of living cells for tissue engineering and regenerative medicine strategies, and for the controlled release of drugs (B.Amsden.Chapter 8: Méthodes de photoréticulation pourconcevoir des hydrogels (Chapter 8: Design of a method for photocrosslinking of hydrogels). Handbook, pp.201-218 (2016)).
[0078] Regarding thermal activation: The temperature range used during PCR can be sufficient to initiate polymerization. Therefore, gelation can occur simultaneously with the start of the nucleic acid amplification reaction. Unlike hydrogels formed by photopolymerization, this system does not require the additional time associated with irradiation with light. This makes this embodiment particularly suitable for rapid PCR applications. In addition, since the stimulus for hydrogel formation is the same as that for nucleic acid amplification, namely temperature, it does not require any additional equipment, such as a UV lamp integrated into the amplification device (e.g., a PCR thermal cycler).
[0079] The present invention provides one or more monomers or prepolymers selected for constructing a hydrogel. Typically, the concentration of the monomer or prepolymer in the composition of the present invention is 2% to 25%. More generally, the present invention provides a polymerizable agent that polymerizes under the action of an external factor. According to the present invention, the factor is light or temperature. Therefore, when the polymerizable agent (i.e., the monomer or prepolymer) is exposed to light (when it is photosensitive) or exposed to temperature (when it is thermosensitive), the latter polymerizes. A hydrogel is then formed.
[0080] Optionally, the composition of the present invention may contain a photoinitiator or a thermal initiator. When a photoinitiator or a thermal initiator is used, its amount is generally selected between 0.02% and 1%.
[0081] It should be noted that the present invention relates to a masterbatch composition intended to be mixed with a biological sample. The sample may or may not include one or more target sequences to be identified by amplification, in particular to identify the presence or absence of a pathogen in the sample.
[0082] Therefore, the masterbatch composition comprises the components necessary for amplifying the target sequence. Therefore, the composition particularly comprises amplification reagents (e.g. nucleic acid bases of dNTPs, MgCl2, reaction buffer) and amplification enzymes (e.g. Taq polymerase, reverse transcriptase).
[0083] Therefore, the composition does not initially contain the target sequence to be amplified. The composition also does not have to contain primers specific to the target sequence, or fluorescent probes for revealing the amplification of the target nucleic acid sequence, because these two elements depend on the target sequence being sought. Logically, when the desired target sequence is known (e.g., a coronavirus-specific sequence), the composition can contain primers and probes specific to that sequence.
[0084] However, in this specification reference is generally made to the compositions of the invention in a state already mixed with target sequences (including primers and probes).The technical effects associated with the polymerization of the polymerizable agents of the invention are observed under conditions using a method for amplifying nucleic acids.
[0085] Typically, the composition also comprises an enzyme for amplifying the nucleic acid, primers more or less specific for the target sequence, one or more fluorescent labeling molecules more or less specific for the target of interest, a reaction buffer and other additives, if necessary.
[0086] The composition of the present invention also comprises a sample (DNA, RNA, plasmid, bacteria, virus, phage, fungus, etc.) to be analyzed under use conditions, and the sample analyzed comprises a target nucleic acid sequence. It should be noted that the sample can initially be in the second mixture, and / or particularly undergo pre-purification. In this case, the sample is mixed with the components of the gel and the PCR reagents. The resulting mixture is a composition of the present invention.
[0087] The composition can be injected into a reaction chamber compatible with a nucleic acid amplification instrument. Thus, the mixture is in a liquid state (more or less viscous) in the reaction chamber, thus being adaptable to reaction chambers of different shapes.
[0088] According to the present invention, the hydrogel formed by polymerizing the polymerizable agent has the effect of locally encapsulating each target nucleic acid sequence while maintaining the diffusion of other components of the composition to enable effective amplification of the target nucleic acid sequence.
[0089] When the composition of the present invention is in a gel state in the reaction chamber, a target nucleic acid amplification process can be performed. In particular, the amplification process can be selected from one of those mentioned above in the specification, in particular conventional or qPCR type PCR, real-time PCR, asymmetric PCR, RT PCR or others; NASBA; 3SR (English "Self-Sustained Sequence Replication (autonomous sequence replication)"); SDA; TMA; RCA; LAMP or MDA (English "multiple displacement amplification (multiple displacement amplification)").
[0090] [ Figure 1 ] shows a block diagram of the method of the present invention. The amplification reaction mixture (mixed PCR) and the polymerizable reagent (polymer + activator) are mixed to form the masterbatch of the present invention (masterbatch mixed polymerase colony). Thus, the masterbatch is ready for use and mixed with a biological sample (target) containing a target sequence.
[0091] Thus, the composition of the invention comprising a target sequence and a primer can be distributed in a reaction chamber of a nucleic acid amplification device (amplification chamber). Then, a factor selected from light or temperature is applied to initiate polymerization of a polymerizable agent. Thus, a hydrogel of the invention is formed. According to the invention, the hydrogel locally encapsulates each target nucleic acid sequence while enabling diffusion of the amplification agent. Then, an amplification process (amplification) can be performed.
[0092] The applicant has found, but is not surprised, that the choice of polymer and, if appropriate, activator is conditional on the state of the hydrogel formed.The hydrogel formed by the composition of the invention has the characteristics of solving the problems mentioned above in the description.
[0093] To select the polymers and activators of the present invention so as to form a hydrogel from the composition of the present invention, one should proceed as follows.
[0094] The first step consists in designing the hydrogel matrix according to the final needs. The main considerations to be taken into account are: a) the chemical origin of the hydrogel components, their compatibility with the protocol; b) the use of functionalized monomers or prepolymers; c) the type of photo- or thermal-crosslinking reaction; d) optionally, the type of photo- or thermal initiator, and the source to be applied, i.e., light or heat, respectively; e) the structure and density of the desired network (percentage of gel, ratio of reagents).
[0095] A variety of natural and / or synthetic materials can be used to form a hydrogel that can be photocrosslinked or heat-crosslinked. Natural substances such as alginate, hyaluronic acid, chitosan, collagen, silk fibroin and gelatin can be applied. However, it should be noted that the change from one batch to another of the hydrogel of natural origin does not always reproduce their mechanical and biochemical properties, and therefore the possibility of obtaining a matrix with a clear property can be limited. The material properties of synthetic hydrogels can be accurately adjusted. In terms of these materials having no biologically relevant functions, certain applications need to introduce specific features present in natural extracellular matrix (ECM) in a highly controlled manner. Synthetic materials can include but are not limited to Pluronics derivatives, polyvinyl alcohol (PVA), poly (acrylic acid), polyethylene glycol (PEG) and polypeptides (Chinese Chem. Lett. 2020; ACS Macro Lett. 2013, 2, 5-9).
[0096] The use of monomers in polymerization is limited by the fact that most of them are cytotoxic and / or carcinogenic, and have an inhibitory effect on the amplification process. In addition, this method often causes an inhomogeneous network. An alternative solution is to use a macromolecular hydrogel precursor (prepolymer), which is functionalized with photoreactive or thermoreactive groups to form a photopolymerizable or thermopolymerizable hydrogel. For example, compared with acrylamide / bisacrylamide systems, two advantages of prepolymers are their low toxicity on the one hand and their low inhibition rate on the other hand. In addition, prepolymers are stable and water-soluble. As discussed above, these molecules have at least one, and may have several reactive functional groups. For example, PEG acrylate and methacrylate derivatives (linear and multi-arm configurations), PEG norbornene derivatives (linear and multi-arm configurations), PEG thiol derivatives (linear and multi-arm configurations), PEG acrylamide and methacrylamide derivatives (linear and multi-arm configurations), polyvinyl alcohol (PVA) derivatives, such as modified polysaccharides of hyaluronic acid derivatives, methacrylic acid dextran can be used in particular. Peptides can be incorporated into PEG-acrylate hydrogels by functionalizing the terminal amino groups of the peptides with acrylate moieties (Biomaterials 2002, 23, 4307-4314).
[0097] There are several types of photo- or thermal-crosslinking reactions. Depending on the amplification reaction and the applied target, in particular the temperature range, a suitable reaction is selected. Preferably, in the context of the present invention, bioorthogonal thiol-ene reactions and dimerization reactions are used.
[0098] Regarding photosensitive polymerization, in bioorthogonal reactions, photoclick polymerization of thiol-norbornene (thiol-ene) is one of the preferred choices here. This polymerization is carried out by a step-growth mechanism, making it possible to produce hydrogels with uniform structure and almost no network defects. It involves a light-mediated orthogonal reaction between multifunctional macromolecular monomers containing norbornene and thiol functional groups at the end. Activated by UV or visible light, the thiol-ene reaction is reflected by the gradual and rapid addition of thiols to the double bonds of the norbornene fragments, forming thioether bonds and free radical mediation (it should be noted that cationic ion mechanisms are also possible). This type of bioorthogonal reaction is insensitive to water and oxygen, does not require the addition of co-initiators or comonomers, and can be carried out under mild, selective and effective reaction conditions. Compared with chain polymerization, this leads to the formation of uniform networks and fast kinetics. The mechanism of step-by-step polymerization allows the acquisition of a homogeneous network with an appropriate mesh, which greatly limits the diffusion of target molecules / cells and amplification products, but enables the diffusion of amplification reagents.
[0099] Another method in the context of photosensitive polymerization is to apply cycloaddition reactions, such as photodimerization. Photodimerization occurs between two identical unsaturated molecules (after activation by light) and leads to the formation of dimers. Different structures containing double bonds can be used, such as coumarin, cinnamate, thymine, anthracene, stilbene, chalcone and dimethylmaleimide (DMMI). They can be integrated into natural or synthetic polymers, for example: conjugates of cinnamate, coumarin and thymine with hyaluronic acid or chondroitin sulfate; cinnamate conjugates with poly (N, N-dimethylacrylamide), PEG containing terminal cinnamate groups and nitrocinnamate groups (Adv. Funct. Mater. 2001, 11, 1); gelatin modified with nitrocinnamate; PVA with coumarin groups; polyacrylamide with DMMI. (Chapter 8: Photo-Crosslinking Methods to Design Hydrogels. Gels Handbook, pp. 201-218 (2016)). The photoreactivity of these compounds can be adjusted by changing the substituents of the photosensitive reaction center. Among the additional advantages of this crosslinking strategy, it should be noted that no initiator or catalyst is required. On the other hand, a high energy supply should be applied to obtain effective crosslinking. UV intensity and gelation time can be reduced in several ways. The first method is to introduce a large number of photodimerizable groups on the core of the prepolymer, which will also increase crosslinking (for example, by introducing photodimerizable fragments over the entire length of the prepolymer backbone, using multi-chain prepolymers). The second is to use a water-soluble sensitizer, such as thioxanthone disulfate, to reduce the energy supply (Polymer 2007, 48, 5599-5611).
[0100] Another group of photoinduced polymerizations includes reactions with azides activated by UV light to form intermediate reactive nitrene radicals. Nitriles can rapidly react with unsaturated bonds to undergo addition reactions, inserting into carbon-hydrogen or nitrogen-hydrogen bonds. Hydrogels can also be formed when nitrene radicals react with primary amines, such as modified chitosan (B. Amsden. Chapter 8: Photo-Crosslinking Methods to Design Hydrogels. Gels Handbook, p. 201-218 (2016)).
[0101] The selection of a suitable photoinitiator (if necessary) is a key task in designing a photocrosslinkable matrix for nucleic acid amplification. A series of important properties should be considered: the photoinitiator should have an absorption spectrum with good overlap with the emission spectrum of the desired light source; a fairly high value of the molar extinction coefficient; good water solubility; stability; the ability to generate free radicals (or other reactive particles); biocompatibility, compatibility with the amplification process, etc. (Biomaterials 2002, 23, 4307-4314; BioTechniques 2019, 66, 40-53).
[0102] About thermosensitive polymerization, in bioorthogonal reaction, Diels-Alder reaction is one of the preferred choices here. It is carried out with a stepwise growth mechanism so that the structure of the hydrogel with uniform structure is almost defect-free. It is related to the orthogonal reaction mediated by the temperature between the multifunctional macromolecular monomer and the dienophile functional group comprising diene. Different structures can be used for conjugated dienes (furans, tetrazines, etc.) and substituted olefins (maleimides, norbornene, etc.). These structures can be integrated into natural or synthetic polymers, such as polyacrylates (European Polymer Journal, 2013, 12, 3998-4007), poly (ether amines) (Polymers, 2019, 11, 930), hyaluronic acid (Polymer Chemistry, 2014, 5, 5116-5123), alginate (Biomaterials, 2015, 50, 30-37). Activated by temperature, Diels-Alder reaction is a free radical-free radical reaction, which produces a six-membered ring. This type of bioorthogonal reaction is insensitive to water and oxygen, does not require the addition of co-initiators or comonomers, and can be performed under mild, selective and efficient reaction conditions. This leads to the formation of a homogeneous network and fast kinetics compared to chain polymerization. The mechanism of stepwise polymerization allows obtaining a homogeneous network with an appropriate mesh that greatly restricts the diffusion of target molecules / cells and amplification products, but enables the diffusion of amplification reagents.
[0103] Another method in the context of thermosensitive polymerization is the dimerization of polymerizable groups such as acrylates. In the presence of a thermal initiator, dimerization occurs between two identical polymerizable functional groups. Different structures containing double bonds can be used, such as (meth) acrylates, (meth) acrylamides or maleimides, and these structures can be integrated into natural or synthetic polymers, such as PEG or polysaccharides (hyaluronic acid, gelatin, etc.). The thermal reactivity of these compounds can be adjusted by changing the substituents of the thermosensitive core. Temperature and gelation time can be reduced in several ways. The first is to introduce a large amount of heat-modifiable groups on the core of the prepolymer, which will also increase crosslinking (for example, by introducing heat-modifiable parts along the entire skeleton of the prepolymer, using multi-arm prepolymers). The second is to use a higher concentration of thermal initiators, while paying attention to compatibility with PCR.
[0104] The selection of an appropriate thermal initiator (when necessary) is a key task in the design of a thermally cross-linkable matrix for nucleic acid amplification. A number of important properties should be considered: the thermal initiator should have a decomposition temperature that overlaps well with the temperatures used during PCR; a reasonably high value for the molar extinction coefficient; good water solubility; stability; the ability to generate free radicals (or other reactive particles); and biocompatibility, especially with the amplification process. Different types of thermal initiators can be used to initiate thermal polymerization: persulfates, neutralized with counterions (ammonium, potassium, sodium, etc.), decompose to sulfate, which forms HSO in aqueous solution. 4- ions and hydroxyl groups, which can initiate polymerization (Catalysis Today, 2015, 257, 297-304); - organic peroxides (methyl ethyl ketone peroxide, benzoyl peroxide, etc.), which undergo symmetric fission (homogeneous fission) to form two free radicals that can initiate polymerization; - azo compounds (2,2'-azobis(isobutyronitrile), 2,2'-azobis[2-(2-imidazolin-2-yl)propane dihydrochloride], etc.), which decompose under the action of heat (or light) to form gaseous nitrogen and carbon free radicals that can initiate polymerization.
[0105] The polymerization process proceeds by the formation and reaction of certain reactive species, namely free radicals or ions. They can be formed as a result of the high chemical reactivity of the participating components themselves (e.g. cations in Michael-type additions); after a specific activation by one or more initiators (e.g. free radicals formed after the oxygen reduction reaction of the APS-TEMED system in the polymer chain), by applying temperature with or without an initiator (e.g. ammonium persulfate (APS), which can be decomposed into free radicals by heating) or by applying light with or without a photoinitiator.
[0106] In the present invention, this last method is used, i.e. the application of light or temperature with or without a photoinitiator or thermal initiator, respectively, for the generation of reactive free radical species. Generally, two main groups of initiators are used in the synthesis of hydrogels for biomedical applications: free radical and cationic photoinitiators or thermal initiators (i.e. those that induce the formation of reactive free radicals or cations in the system, respectively). The use of cationic photoinitiators or thermal initiators is possible, but complicated, because they lead to the formation of protonic acids, which are harmful to cells and enzymes, and which can inhibit the amplification process.
[0107] In the case of photosensitive polymerization, a cleavable photoinitiator (Type I) or a biomolecular photoinitiator (Type II) can be provided. Type I photoinitiators include, but are not limited to, benzoin and acetophenone derivatives, such as Irgacure photoinitiators (Irgacure-2959; Irgacure-184; Irgacure-651; Irgacure-369; Irgacure-907, etc.), phenyl-2,4,6-trimethylbenzoylphosphinate lithium (LAP), etc. Under the action of light, these compounds decompose into two parts with free radical centers, which can promote subsequent polymerization. Generally, this type of compound has a maximum in the absorption spectrum of about 300 to 400nm and can therefore be used for UV polymerization. In contrast, Type II photoinitiators, such as camphorquinone, thioxanthone, and benzophenone, have a maximum in the absorption spectrum in the visible light range and can be used for polymerization mediated by visible light. Their mechanism of action is based on the extraction of hydrogen present in the co-initiator (e.g., triethanolamine) and the generation of a second free radical. Typically, in order to induce effective photogelation, a promoter, such as N-vinylpyrrolidone, is required. However, compared to type I photoinitiators, type II is less cytotoxic and more soluble in water. One of the most widely used UV light-sensitive photoinitiators is Irgacure-2959, due to its moderate solubility in water, its low cytotoxicity and its minimal immunogenicity. However, it is characterized by a relatively low initiation efficiency and molar extinction coefficient within the UV-A spectral range. A good alternative is to use LAP, which is more effective and biocompatible, and which is well soluble in water as a lithium salt. In addition, LAP also absorbs in the blue light region (405nm). V-50 (2,2'-azobis(2-methylpropionamidine) dihydrochloride) and V-086 (2,2'-azobis(N-(2-hydroxyethyl)-2-methylpropionamide)) (BioTechniques 2019, 66, 40-53; B. Amsden. Chapter 8: Photo-Crosslinking Methods to Design Hydrogels. Gels Handbook, p. 201-218 (2016)) can also be implemented.
[0108] The optimal concentration of photoinitiator or thermal initiator is an important parameter for the polymerization of hydrogels used in the amplification process. A high concentration of initiator is able to generate more free radicals, which generally leads to a higher conversion rate of monomers. However, too high a concentration of initiator can be harmful to amplification because free radicals can damage cellular macromolecules such as cell membranes, proteins and nucleic acids, and fluorophores. This leads to inhibition of amplification. Preferably, a concentration of 0.02% to 1% is used, depending on the applied initiator, the intensity of light or temperature, and the mechanical dynamics of the polymerization.
[0109] Finally, the variation of gel percentage and component ratio allows to obtain the desired structure and network density. The gel matrix should have a uniform structure with appropriate mesh, which limits the diffusion of target molecules / cells and amplification products while enabling the diffusion of amplification reagents. The average pore size in the range of 100 μm to 5 nm can prevent diffusion and therefore prevent the mixing of target sequences while enabling the diffusion of amplification reagents. Within this range, the concentration of the gel can be varied to affect two parameters: a) the size of the molecular colony or polymerase colony; b) the limiting ability of the gel matrix to different types of targets (DNA, RNA, plasmid, bacteria, virus, bacteriophage, etc.). As previously noted (US6485944 of GM Church et al.; EP1999268 of ABChetverin et al., US6001568 of ABChetverin et al.), the increase of gel percentage leads to a reduction in molecular colony size. The concentration of the gel also has a considerable effect on the ability of the matrix to capture different targets.
[0110] Different reaction chambers can be used. They can include, but are not limited to flat chips, boxes, narrow or elongated reaction chambers, i.e. rods or capillary types, particularly folded or wound in flat boxes, so that they can be placed in standard PCR thermal cyclers. The chamber can have different suitable volumes, which are confined in a closed space, except for the inlet / outlet holes for pouring the mixture. The reaction chamber consists of different parts. In a specific embodiment of the present invention, the lower part of the chamber is in direct contact with the heating system on one side and in direct contact with the mixture (liquid or gel) on the other side. Preferably, it is flat to ensure better adhesion of the gel matrix. The upper part, i.e. the visible part, is also preferably planar and is closely attached to the bottom. The upper part should be transparent to the wavelength of light so that polymerization can be initiated, and is also transparent at the wavelength of light for the amplification reaction detection process. The distance between the bottom and the top can be included between 1 μm and 1 mm, preferably a distance that can arrange a monolayer amplification product, i.e., a molecular colony. The other two dimensions (length and width) should be larger (ideally with a minimum factor of 10) in order to provide enough surface area to place the different targets and their amplification products. To avoid gel dehydration, the inlet / outlet holes should be closed in different ways: for example, mechanically, integrated by the design of the chamber; using an external adhesive membrane and / or using pressure.
[0111] According to a first embodiment of the invention, the composition is exposed to light of a selected wavelength and intensity for a predetermined period of time. Light of different wavelengths (UV from 200 to 400 nm or visible light from 400 to 800 nm) and different intensities can be applied. The irradiation intensity and dosage must be considered because they are necessary for initiating polymerization and increasing photoinitiation. It should be noted that there is no linear ratio between the intensity of UV light and photoinitiation, and that too high intensity values may cause the resulting polymer to degrade into an inhomogeneous gel. In addition, too high an intensity may cause the destruction of reagents necessary for amplification. The UV intensity range is adjusted to 1 to 20 mW / cm 2 and allow a gel to form within 1 to 5 minutes.
[0112] According to a second embodiment of the invention, the composition is exposed to a threshold temperature. In particular, it may be sufficient to start PCR to initiate polymerization of the composition of the invention.
[0113] When the gel is formed, the nucleic acid sequences are fixed in the matrix of the gel. Amplification can then be performed on an amplification device. Different machines can be mentioned, such as the MasterCycler Nexus flat thermal cycler from Eppendorf; the PCR ProFlex system from Applied Biosystems; the QuantStudio 3D from Applied Biosystems; the SmartCycler from Cepheid or the Applicant's Chronos.
[0114] Implementation
[0115] Examples 1 to 5 relate to hydrogels obtained from compositions comprising a photosensitive polymerizable agent of the invention, and Examples 6 to 8 relate to hydrogels obtained from compositions comprising a thermosensitive polymerizable agent of the invention. Unless otherwise stated, PCR was performed on a commercially available Chronos machine.
[0116] Example 1: Naked DNA in Symmetric PCR
[0117] Bioorthogonal thiol-ene reactions were used to form hydrogels. Equimolar amounts of four-arm-PEG-SH (molecular weight of 10,000 g / mol, Laysan Bio) and four-arm-PEG-norbornene (molecular weight of 10,000 g / mol, Sigma) were selected for the construction of gels with a percentage (%) w / v in the range of 5 to 7%. LAP (lithium phenyl-2,4,6-trimethylbenzoylphosphinate, Sigma) was used as a photoinitiator at a ratio of 0.02% (w / V). The following amplification reagents were used: 1 U of SsoAdvancedUniversal SYBR Green Supermix (Bio-Rad), 8 U of Platinum TM Taq DNA polymerase (ThermoFisher SCIENTIFIC), 0.4 μM of primers targeting the 16S region of bacteria, with a substrate length of 740 pb. Optionally, additional intercalating dye ( Fluorescent DNA dye (Jena Bioscience) or Dye (20X in water, Biotium).
[0118] The mixture containing all components and the target DNA derived from Bacillus subtilis (B. Subtilis) was adjusted with 25 μL of ddH2O and injected into the reaction chamber. Depending on the thermal cycler used, the chamber is characterized by the following dimensions: SmartCycler from Cepheid (chamber made of 5×5×1 mm plastic, 25 μL); Flat thermal cycler MasterCycler Nexus from Eppendorf (chamber of 9×9×0.3 mm, 25 μL (silane-treated glass microscope slide + frame seal chamber (Bio-Rad) + cover glass made of plastic)); Chronos (chamber of 10×10×0.25 mm, 25 μL, with a bottom made of Al and a cover made of cyclic olefin copolymer (COP)). In this case, a SmartCycler machine from Cepheid was used.
[0119] By applying UV light (365 nm, 3.4 mW / cm 2 ) activated thiol-norbornene reaction, a gel was already formed from the photosensitive composition after 1 minute at room temperature.
[0120] PCR was performed by initial denaturation at 95°C for 2 min, followed by 35 cycles of denaturation at 95°C for 5 s and extension at 60°C for 30 s.
[0121] The DNA molecular colonies of Bacillus subtilis were observed using an Axiovert 100 (ZEISS, Germany) fluorescence microscope (10 4 , 10 3 , 10 2 copies and negative control).
[0122] [ Figure 2 ] shows that after PCR, 10 4 , 10 3 , 10 2 Corresponding photographs of the hydrogels of the samples with 10 copies and the negative control. Figure 2 ] Also shown is a curve of the fluorescence signal as a function of PCR cycles and the corresponding Ct values.
[0123] Photos were captured using a Samsung Galaxy S10. The negative control contained 20 to 30 molecular colonies due to amplification of E. coli impurities present in the SsoAdvanced Universal SYBR Green Supermix, which can be amplified with very sensitive primers targeting the 16S region.
[0124] Example 2: Naked DNA in Symmetric PCR
[0125] In this example, bioorthogonal thiol-ene reactions were used to form the polymer matrix. More specifically, equimolar amounts of two-arm-PEG-SH (molecular weight 3,400 g / mol, Laysan Bio) and eight-arm-PEG-norbornene (tripentaerythritol) (molecular weight = 20,000, Jenkem Technology) were considered for the construction of gels with a percentage (%) w / V in the range of 6 to 11%.
[0126] LAP (lithium phenyl-2,4,6-trimethylbenzoylphosphinate, Sigma) was used as a photoinitiator in an amount of 0.02% (w / V). The same amplification reagents as in Example 1 were used.
[0127] The mixture containing Bacillus subtilis (10 3 A composition of a target DNA sequence containing 10 copies of a target DNA sequence is prepared and injected into a reaction chamber.
[0128] The UV light (365 nm, 3.4 mW / cm 2 ) to initiate polymerization of the composition. After 1 minute, a gel was formed by stepwise thiol-norbornene polymerization (at room temperature).
[0129] [ Figure 3 ] shows that the number and size of the spots (corresponding to the polymerase colonies) vary depending on the percentage of the gel: 80 to 100 μm for 10.8% gels (left photo), 100 to 120 μm for 8.8% gels (middle photo), and 150 to 160 μm for 6% gels (right photo). An increase in gel concentration leads to the formation of fewer and smaller spots. The stronger signals of the 6% and 8.8% gels can be explained by the higher efficiency of PCR, which is due to the larger size of the mesh of the matrix of these gels compared to the mesh of the 10.8% gel. Larger meshes lead to freer diffusion of amplification reagents, in particular relatively large molecules such as enzymes. On the other hand, larger meshes also lead to increased diffusion of PCR products, which is the origin of larger spots. PCR was performed on a Cepheid SmartCycler device according to the protocol of Example 1, and photos were captured with a Samsung Galaxy S10 camera on an Axiovert 100 (ZEISS, Germany) fluorescence microscope.
[0130] [ Figure 3 ] Also shown is a curve of the fluorescence signal as a function of PCR cycles and the corresponding Ct values.
[0131] [ Figure 3] The derivative of the fluorescence signal versus temperature is also shown as a function of temperature. The peak observed corresponds to the melting point of the product formed by amplification. In this case, a value of about 88° C. is obtained, which is expected for amplified DNA.
[0132] Example 3: Naked DNA in Symmetric PCR
[0133] In this example, dimerization was used to form a polymer matrix: an eight-arm PEG based on nitrocinnamate (molecular weight 21.400 g / mol) was used for the construction of a gel with a percentage (%) w / V of 10%. The following amplification reagents were used: 5U SD polymerase Hotstart (Bioron), buffer (Incomplete SD polymerase reaction buffer (10x), Bioron), 3mM MgCl2 buffer (Bioron), 0.4μM primers targeting the bacterial 16S region, with a matrix length of 740pb. DNA intercalating dye was added at a concentration of 2X Dye, 20X in water (Bitium) The composition containing all components including naked DNA target derived from E. coli was adjusted with 25 μL of ddH2O and injected into the Chronos reaction chamber.
[0134] After 1 minute at room temperature, the cells were heated to 40 ℃ by applying UV light (365 nm, 3.4 mW / cm 2 ) activated dimerization reaction to form a gel obtained from the photosensitive composition. The PCR amplification process was carried out according to the following protocol: initial denaturation at 95°C for 2 minutes, 35 cycles of denaturation at 98°C for 5 seconds and extension at 60°C for 30 seconds. Molecular colonies were observed using an Axiovert 100 (ZEISS, Germany) fluorescence microscope.
[0135] [ Figure 4 ] shows nine photographs of hydrogels formed from different embodiments of the composition of the present invention, the composition having the same initial concentration of target sequence (10 3 copies) or zero (see control image with negative sample).
[0136] [ Figure 4 The first row of ] shows the first photo captured with the Hamamatsu camera (10 3 The negative control contained a small number of molecular colonies due to the presence of impurities amplified by very sensitive primers targeting the 16S region.
[0137] Example 4: Naked DNA in asymmetric PCR
[0138] In this example, bioorthogonal thiol-ene reactions were used to form the polymer matrix: equimolar amounts of four-arm-PEG-SH (molecular weight of 10,000 g / mol, Laysan Bio) and four-arm-PEG-norbornene (molecular weight of 10,000 g / mol, Sigma) were considered for the construction of a gel with a percentage (%) w / V of 6.4%. LAP (lithium phenyl-2,4,6-trimethylbenzoylphosphinate, Sigma) was used as a photoinitiator in an amount of 0.02% (w / V). The following amplification reagents were used: 5U from Hot Start SD Polymerase (Bioron), buffer (Incomplete SD Polymerase Reaction Buffer (10x), Bioron), 3mM MgCl2 (Bioron), a pair of custom primers targeting the FimH gene of Escherichia coli (E. Coli) with a matrix length of 400pb. It has been added at a concentration of 1X Dye, 20X embedding dye (Bitium) in water.
[0139] The target sequence containing E. coli (10 4 copies of naked DNA) and injected into the Chronos reaction chamber.
[0140] The UV light (365 nm, 3.4 mW / cm 2 ) activated stepwise growth in the thiol-norbornene click reaction to form a gel from the photosensitive composition at room temperature after 1 minute.
[0141] The PCR amplification protocol was: initial denaturation at 92° C. for 2 min, 40 cycles of denaturation at 92° C. for 5 sec and extension at 64° C. for 30 sec. Molecular colonies were visualized in real time with a Chronos camera.
[0142] Example 5: Viruses in RT-PCR
[0143] The experimental protocol was the same as that used in Example 1, except that the reverse transcriptase iScript™ (Bio-Rad) was used for reverse transcription. In addition, the amplification protocol included a reverse transcription step at 60°C for 60 seconds. A pair of custom primers targeting MS2 with a length of 200 pb was used. Molecular colony network of MS2 (10 3 copies) visualized on a Chronos machine.
[0144] [ Figure 4 The third row of ] shows pictures taken with the camera of the Chronos machine (10 3 copies).
[0145] Example 6: Naked DNA in PCR
[0146] This example implements the dimerization of acrylates for forming a polymer matrix: 4-arm PEG-acrylate (molecular weight 20,000 g / mol, Laysan Bio) was considered for the construction of a gel at 10% w / V. VA-044 (2,2'-azobis[2-(2-imidazolin-2-yl)propane dihydrochloride], TCI Chemicals) was used as a thermal initiator in an amount of 0.07% (w / V). The following amplification reagents were used: 6U hot start SD polymerase (Bioron), 10X buffer containing 250mM potassium acetate (KOAc), 83mM ammonium sulfate ((NH4)2SO4), 30mM magnesium chloride (MgCl2), 1.5M Tris-HCl and 1V% Twee-20, 0.2μM dNTP mix (Sigma) and 0.4μM primers targeting the 16S region of bacteria with a matrix length of 740pb. Optionally, additional intermediate dyes ( Fluorescent DNA dye (JenaBioscience) or Dye (20X in water, Biotium)).
[0147] The mixture containing all components and the target DNA derived from Bacillus subtilis was adjusted with 25 μL of ddH2O and injected into the reaction chamber. Depending on the thermal cycler used, the chamber is characterized by the following dimensions: SmartCycler from Cepheid (chamber made of 5×5×1 mm plastic, 25 μL); MasterCycler Nexus, a planar thermal cycler from Eppendorf (chamber of 9×9×0.3 mm, 25 μL (silane-treated glass microscope slide + frame seal chamber (Bio-Rad) + cover glass made of plastic)); Chronos (chamber of 10×10×0.25 mm, 25 μL, with a bottom made of Al and a cover made of cyclic olefin copolymer (COP)). The Chronos machine was used here.
[0148] The gel formed by the thermosensitive composition is formed during PCR due to the cycling between the denaturation temperature and the extension temperature. In fact, the threshold temperature enables the thermal initiator to polymerize through the acrylic acid functional groups of the four-arm-PEG.
[0149] PCR was performed by initial denaturation at 95°C for 2 min, followed by 35 cycles of denaturation at 95°C for 5 s and extension at 60°C for 30 s.
[0150] Bacillus subtilis DNA molecular colonies were observed using an Axiovert 100 (ZEISS, Germany) fluorescence microscope, and photos were captured using an Apple iPhone 11 camera.
[0151] [ Figure 4 The fourth row of ] shows two photos captured with an Apple iPhone 11 (10 3 The negative control contained a small number of molecular colonies due to the presence of impurities amplified by very sensitive primers targeting the 16S region.
[0152] Example 7: Naked RNA in RT-PCR
[0153] The experimental protocol was that used in Example 6, except that the reverse transcriptase LAMP (New England Biolabs) was used for reverse transcription, and the amplification protocol also included a reverse transcription step at 60°C for 60 seconds. A pair of custom primers targeting MS2 with a matrix length of 200 pb was used instead of the primers previously used to target the 16S gene of Bacillus subtilis. Molecular colonies of naked RNA MS2 were visualized with the camera of the Chronos machine. Figure 4 The fifth row of ] shows two photos captured by the camera of the Chronos machine (10 3 The negative control contained a small number of molecular colonies due to the presence of impurities amplified by very sensitive primers targeting the 16S region.
[0154] Example 8: Viruses in RT-PCR
[0155] This protocol is the same as that used in Example 6, except that the reverse transcriptase LAMP (New England Biolabs) was used for reverse transcription, and the amplification protocol also included a reverse transcription step at 60°C for 60 seconds. A pair of custom primers targeting MS2 was used with a matrix length of 200 pb. Molecular colonies of bacteriophage MS2 were observed with the camera of the Chronos machine.
[0156] [ Figure 4 The sixth row of ] shows a picture taken with the camera of the Chronos machine (10 3 copies).
[0157] In view of the embodiments related to photopolymerization, the applicant has developed a device that is particularly suitable for using the composition of the present invention. Therefore, this specification also discloses an invention related to a device for amplifying nucleic acid sequences. The device can be defined as follows:
[0158] A device for amplifying a nucleic acid sequence, comprising a thermal cycler and amplification reagents, wherein the thermal cycler is arranged to perform a series of thermal cycles using a reaction mixture for amplifying a nucleic acid containing one or more target nucleic acid sequences, wherein the amplification reagents contain specific primers for the target nucleic acid sequences, fluorescent probes for revealing the amplification of the target sequences, and a nucleic acid amplification enzyme, wherein the reaction mixture also contains a photosensitive reagent that can polymerize to form a gel when exposed to light from a light source; the device also includes a reaction chamber, a light source, and a light source controller, wherein the reaction chamber is disposed in the thermal cycler and is configured to receive the nucleic acid amplification reaction mixture, wherein the light source is directed toward the reaction chamber, and wherein the light source controller facilitates turning it on or off and controls the wavelength and intensity of the light.
[0159] Thus, the device is arranged to produce a stimulus to the light-sensitive agent, causing the agent to polymerize when it is exposed to light from a light source. This results in the formation of a gel.
[0160] In other words, when the light source illuminates the reaction mixture, a hydrogel is formed that partially encapsulates each target nucleic acid sequence and amplification reagents.
[0161] The present invention may also be commercialized in the form of a kit comprising the composition described above and a device for amplifying a nucleic acid sequence. Therefore, the present invention also relates to a kit for amplifying a nucleic acid sequence, comprising (i) a composition of the present invention and (ii) a device for amplifying a nucleic acid sequence, the device comprising a thermal cycler arranged to perform a series of thermal cycles with the composition, a reaction chamber arranged in the thermal cycler and arranged to receive the nucleic acid amplification reaction mixture, and also comprising a light source directed to the reaction chamber and a controller for the light source so as to switch it on or off and control the wavelength of the light.
Claims
1. A masterbatch composition for amplifying nucleic acid sequences, which is intended to be mixed with a biological sample containing one or more target nucleic acid sequences and specific primers for said target nucleic acid sequences, and a fluorescent probe for revealing the amplification of said target nucleic acid sequences, said composition comprising reagents and a nucleic acid amplification enzyme, characterized in that The composition further comprises a polymerizable agent that polymerizes under the influence of a stimulus selected from a thermal stimulus and a light stimulus so as to form a hydrogel that locally encapsulates each target nucleic acid sequence when the composition is exposed to the stimulus.
2. A composition as claimed in claim 1, wherein the polymerizable agent is selected from a photosensitive agent that polymerizes when exposed to light, preferably ultraviolet light, and a thermosensitive agent that polymerizes when exposed to a threshold temperature.
3. A composition as claimed in any preceding claim, wherein the polymerisable agent is selected from PEG and other water-soluble polymers compatible with PCR.
4. A composition as claimed in any preceding claim, wherein the polymerisable agent is selected from PEG and other water-soluble polymers compatible with PCR, capable of undergoing a photosensitive or thermosensitive reaction such as a free radical, ionic, dimerisation or Diels-Aider reaction.
5. A composition as claimed in any preceding claim, wherein the polymerisable agent is present in an amount of 2% to 25% by weight, preferably 5% to 15% by weight per volume (w / V).
6. A composition as claimed in any preceding claim, further comprising an initiator, the initiator being selected from a photoinitiator and a thermal initiator, the photoinitiator being preferably lithium phenyl-2,4,6-trimethylbenzoylphosphinate (LAP), the thermal initiator being preferably 2,2'-azobis[2-(2-imidazolin-2-yl)propane] dihydrochloride, the content being 0.02% to 1% by weight per unit volume (w / V).
7. A composition as claimed in any preceding claim, comprising primers specific for the target nucleic acid sequence and a fluorescent probe for revealing amplification of the target nucleic acid sequence.
8. A composition according to any preceding claim, characterized in that The composition remains liquid for a period of hours to months, preferably days to months, before application of the stimulus, and the composition forms the hydrogel within a period of less than or equal to 10 minutes, preferably less than or equal to 1 minute, after application of the stimulus.
9. A method for amplifying a nucleic acid sequence, comprising the steps of: (i) providing a composition according to claims 1 to 8; (ii) mixing the composition with a biological sample to be analyzed; (iii) applying a stimulus selected from a thermal stimulus and a light stimulus to polymerize the mixture of step (ii) to obtain a hydrogel; and (iv) exposing the hydrogel to an amplification reaction of an acid sequence.
10. The method of claim 9, wherein the providing step (i) is continued for a period of several hours to several months, preferably several days to several months.
11. The method according to one of claims 9 and 10, wherein the reaction is a polymerase chain reaction.
12. The amplification method of any one of claims 9 to 11, wherein step (iii) of applying a stimulus comprises exposing the composition to UV light or a threshold temperature.
13. The amplification method according to any one of claims 9 to 12, wherein the hydrogel is obtained within a time period shorter than or equal to 10 minutes, preferably shorter than or equal to 1 minute after applying the stimulus.
14. The amplification method according to any one of claims 9 to 13, wherein step (iii) comprises a reaction selected from a bioorthogonal thiol-ene reaction and a dimerization reaction.
